BDgene Advances CRISPR-Based BD111 for Herpes Keratitis with IND Filing
Shanghai BDgene Technology Co., Ltd has completed efficacy and preliminary safety studies for BD111, its...
MicroPort NeuroTech Lists in Hong Kong with $43.3 Million IPO
MicroPort NeuroTech Limited has successfully completed its initial public offering (IPO) on the Hong Kong...
Bayer’s Kerendia Approved by China’s NMPA for Diabetic Kidney Disease
The National Medical Products Administration (NMPA) has approved Bayer’s (ETR: BAYN) Category 1 drug Kerendia...
Hengrui Medicine’s SHR3680 Approved for High Burden Metastatic Prostate Cancer
China’s Hengrui Medicine Co., Ltd. (SHA: 600276) announced that its Category 1 drug SHR3680 has...
Legend Biotech Collaborates with Trinity College Dublin on CAR-T Therapies for Solid Tumors
China-based Legend Biotech Corporation (NASDAQ: LEGN) has formed a partnership with Trinity College Dublin and...
AnchorDx and West China Hospital Collaborate on Lung Cancer Early Diagnosis
Guangzhou-based AnchorDx and West China Hospital of Sichuan University have entered into a transfer agreement...
Akeso Biopharma’s Cadonilimab Approved for Cervical Cancer Treatment
China-based biotech company Akeso Biopharma (HKG: 9926) announced that its self-discovered bispecific antibody (BsAb) cadonilimab...
Humanwell Healthcare Wins NMPA Approval for RFUS-144 in Pain Management
China-based Humanwell Healthcare (Group) Co., Ltd (SHA: 600079) announced receiving approval from the National Medical...
LaNova Medicines Secures Series B Funding to Advance Oncology Pipeline
China-based LaNova Medicines has successfully closed a Series B financing round, raising an undisclosed sum...
GenFleet Collaborates with BioLineRx to Develop Motixafortide for Pancreatic Cancer in China
China-based GenFleet Therapeutics has entered into a collaboration with Israel’s BioLineRx Ltd (NASDAQ: BLRX) to...
Henlius and Palleon Partner on HER2-Targeted Antibody-Sialidase Fusion Protein
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) announced a strategic partnership with US-based Palleon Pharmaceuticals...
Lundbeck Initiates TALISMAN Study on Multiple System Atrophy in China and EU
Danish-based Lundbeck (OTCMKTS: HLUBF) has announced plans to initiate a global investigational study on multiple...
OCON Healthcare Partners with Bio Genuine for China Marketing Rights and Women’s Health Product Development
Israel-based OCON Healthcare, a specialist in uterine drug delivery, has entered into a license agreement...
Expeclinlab Raises RMB 185 Million to Boost Clinical Mass Spectrometry Business
Focused Photonics Inc’s (SHE: 300203) subsidiary Expeclinlab has secured RMB 185 million (USD 27.7 million)...
Beijing Luzhu Biotechnology Secures Series C Funding for Meningococcal Vaccine Development
China-based Beijing Luzhu Biotechnology Co., Ltd has reportedly secured an undisclosed amount in a Series...
Eli Lilly’s Donanemab Receives Tacit Approval for Alzheimer’s Clinical Trial in China
The Center for Drug Evaluation (CDE) website indicates that US major Eli Lilly’s (NYSE: LLY)...
Hainan Lecheng Partners with Fosun Pharma on Innovative Medical Devices and Diagnostics
The Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration has formed a partnership with...
Recbio’s R520A mRNA COVID-19 Vaccine Receives Clinical Approval in the Philippines
China-based Jiangsu Recbio Technology Co., Ltd has announced receiving clinical trial approval from the Food...
Pfizer’s Besponsa First Prescribed in China for Leukemia Treatment
US major Pfizer (NYSE: PFE) has announced the first prescriptions for its leukemia therapy Besponsa...
Kelun Pharmaceutical Receives USD 30 Million from MSD for Licensing Deal
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) has announced receiving USD 30 million from...